Oscar Health, Inc. Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer
Oscar Health, Inc. (OSCR) had Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer of $19.82 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position
us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger · last filed 2026-08-07
- 2026-06-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer $19.82M.
- 2026-03-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer $29.98M.
- 2025-12-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer $40.78M.
- 2025-09-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer $344.42M.
| Period end | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer |
|---|---|
| 2026-06-30 | $19.82M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $29.98M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $40.78M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $344.42M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 |
| 2024-12-31 | $47.75M 10-K · filed 2026-02-13 |
| 2024-09-30 | $50.95M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $81.93M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $16.30M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $30.10M 10-K · filed 2025-02-20 |
| 2023-09-30 | $72.65M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $165.73M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $241.11M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $516.09M 10-K · filed 2024-02-15 |
| 2022-09-30 | $326.32M 10-Q · filed 2022-11-09 |
| 2021-12-31 | $833.93M 10-K · filed 2022-02-25 |
| 2021-09-30 | $836.65M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $801.42M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $326.18M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $140.38M 10-K · filed 2022-02-25 |